Literature DB >> 31816392

The elucidation of key factors for oral absorption enhancement of nanocrystal formulations: In vitro - in vivo correlation of nanocrystals.

Masaaki Imono1, Hiromasa Uchiyama2, Shinpei Yoshida3, Shiro Miyazaki4, Naomi Tamura3, Hidekazu Tsutsumimoto4, Kazunori Kadota2, Yuichi Tozuka5.   

Abstract

Nanocrystal formulation is a well-established approach for improving oral absorption of poorly water-soluble drugs.(Noyes and Whitney, 1897; Shah et al., 2016) However, it is difficult to predict the in vivo performance of nanocrystal formulations from in vitro dissolution studies. The object of the present study was to investigate the in vitro-in vivo correlation of nanocrystal formulations of different particle sizes. A microsuspension and three nanosuspensions with different particle sizes for model drugs, fenofibrate and megestrol acetate, were prepared. In the comparison between the microsuspension and the nanosuspension having the smallest particle sizes, drug permeation rates from the nanosuspension were about 3-fold higher in the dissolution-permeation study. On the other hand, the solubility enhancement effect due to nanocrystal formation was only up by 1.4-fold, suggesting that nanocrystal formulations dramatically improved not the solubility but the apparent permeability. The oral absorption rate in rats increased with particle size reduction. There were positive and very strong correlations (R2 > 0.95) between the in vitro permeation rate and in vivo maximum absorption rate. We concluded that the enhanced permeability rate due to nanocrystal formation is the main factor for improving oral absorption, and the in vitro dissolution-permeation study could be useful for predicting oral absorption enhancement of nanocrystal formulations.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Dissolution-permeation study; Fenofibrate; Megestrol acetate; Nanocrystal; Oral absorption enhancement; Permeability

Year:  2019        PMID: 31816392     DOI: 10.1016/j.ejpb.2019.12.002

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  8 in total

1.  Development of Solvent-Free Co-Ground Method to Produce Terbinafine Hydrochloride Cyclodextrin Binary Systems; Structural and In Vitro Characterizations.

Authors:  Balázs Attila Kondoros; Orsolya Jójárt-Laczkovich; Ottó Berkesi; Piroska Szabó-Révész; Ildikó Csóka; Rita Ambrus; Zoltán Aigner
Journal:  Pharmaceutics       Date:  2022-03-30       Impact factor: 6.525

Review 2.  Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications.

Authors:  Elide Zingale; Angela Bonaccorso; Claudia Carbone; Teresa Musumeci; Rosario Pignatello
Journal:  Pharmaceutics       Date:  2022-03-23       Impact factor: 6.525

3.  Non-Effective Improvement of Absorption for Some Nanoparticle Formulations Explained by Permeability under Non-Sink Conditions.

Authors:  Kazuya Sugita; Noriyuki Takata; Etsuo Yonemochi
Journal:  Pharmaceutics       Date:  2022-04-07       Impact factor: 6.525

4.  Mechanisms and Extent of Enhanced Passive Permeation by Colloidal Drug Particles.

Authors:  Akshay Narula; Rayan Sabra; Na Li
Journal:  Mol Pharm       Date:  2022-08-23       Impact factor: 5.364

5.  Dose-Dependent Solubility-Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions.

Authors:  Kazuya Sugita; Noriyuki Takata; Etsuo Yonemochi
Journal:  Pharmaceutics       Date:  2021-03-02       Impact factor: 6.321

6.  Applicability of an Experimental Grade of Hydroxypropyl Methylcellulose Acetate Succinate as a Carrier for Formation of Solid Dispersion with Indomethacin.

Authors:  Hiroshi Ueda; Yuya Hirakawa; Hironori Tanaka; Tetsuya Miyano; Katsuji Sugita
Journal:  Pharmaceutics       Date:  2021-03-08       Impact factor: 6.321

7.  The Evaluation of Meloxicam Nanocrystals by Oral Administration with Different Particle Sizes.

Authors:  Yao Yu; Yang Tian; Hui Zhang; Qingxian Jia; Xuejun Chen; Dongzhou Kang; Yimeng Du; Shenghan Song; Aiping Zheng
Journal:  Molecules       Date:  2022-01-10       Impact factor: 4.411

Review 8.  Progress in the development of stabilization strategies for nanocrystal preparations.

Authors:  Jingru Li; Zengming Wang; Hui Zhang; Jing Gao; Aiping Zheng
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.